Discontinuation report OCTOSTIM LIQ INJ. 15MCG/ML

Last updated on 2021-07-08 History
Report ID 138144
Drug Identification Number 02024179
Brand name OCTOSTIM LIQ INJ. 15MCG/ML
Common or Proper name Desmopressin Acetate Injection
Company Name FERRING INC
Market Status MARKETED
Active Ingredient(s) DESMOPRESSIN ACETATE
Strength(s) 15MCG
Dosage form(s) LIQUID SOLUTION
Route of administration INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS
Packaging size Cartons of 10 ampoules
ATC code H01BA
ATC description POSTERIOR PITUITARY LOBE HORMONES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-04-30
Actual discontinuation date 2021-04-29
Remaining supply date 2021-04-29
Discontinuation status Reversed
Discontinuation decision reversal Yes
Information on remaining supply 15 mcg stock anticipated to deplete by 30-Apr-2021
Company comments For patients, please discuss alternative treatment options with your health care professional.
Health Canada comments
Contact Address 200 YORKLAND BLVD
TORONTO, ONTARIO
CANADA M2J 5C1
Company contact information 1-800-263-4057

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-07-08 French Compare
v9 2021-07-08 English Compare
v8 2021-04-30 English Compare
v7 2021-04-29 French Compare
v6 2021-04-29 English Compare
v5 2021-04-27 English Compare
v4 2021-04-27 French Compare
v3 2021-04-27 French Compare
v2 2021-04-27 English Compare
v1 2021-04-27 English Compare